"CureDuchenne was formed in response to the precise needs of those who live with Duchenne and their families. From creating the first Duchenne-specific physical therapy program to funding enabling studies for human clinical trials for eteplirsen, the first-ever FDA approved drug for Duchenne patients, we believe in fighting Duchenne from every angle. At CureDuchenne, we care about you, your children and the quality of the life you live together. And we are striving to make the future better."

In this episode of Open Book, we here from Hawken Miller, Content Strategist for CureDuchenne (https://cureduchenne.org @cureduchenne). Enjoy!